1-Collages Al Sam 1600

Who we are

Our group is a friendly, voluntary association of men who have been diagnosed as having prostate cancer, and their partners. Such men have either undertaken treatment for prostate cancer, or are evaluating the various treatment options. We are not funded by any governmental or private body. Our activities are undertaken by members who contribute their time voluntarily. Expenditure made by the group is sourced through donations and fund-raising activities. There is no membership fee.

Role of the group

When a man has indications of prostate cancer it usually comes as a nasty shock to him, his family and friends. When making decisions about diagnosis, treatment options and rehabilitation there are benefits from discussing things with people who have undergone those processes.

Our group's role is to:

  • provide information, support and assistance to men who have been diagnosed with prostate cancer and/or been treated for prostate cancer, and their partners
  • provide information to anyone who has an interest in or concern about prostate health, including people who have not yet been diagnosed as having prostate cancer, particularly those who have a higher than normal risk of prostate cancer because of their age, ethnicity or family history)
  • promote awareness within the broader community of the incidence of prostate cancer and the importance and benefits of early detection
  • provide assistance to the Prostate Cancer Foundation of Australia (PCFA)
  • identify information resources that can be accessed by anyone who has a need for information about prostate health, diagnosis and treatment options

While the group and its members do not provide medical advice they can help the newly diagnosed man, his partner and those concerned about his welfare to understand the options available, and how these options can be accessed. They can also provide views on what may lie ahead after treatment has been undertaken.

We perform our role through a number of means. Details about how we can help you are provided on this page. However many of our members make their initial contact through attending one of our regular monthly meetings. Those meetings are an excellent starting point for many people who seek advice about prostate cancer.  

Regular monthly meetings

Informal monthly meetings are held in the evening on the 3rd Wednesday of each month except in December. At most meetings there is a presentation from a person who has expertise in some particular area of interest. Details about these meetings and the next scheduled meeting are given on this page.

1-Al-Sameraaii 800
We also hold regular monthly coffee and chat mornings at 10:00 am on the second Tuesday of each month (except January). Details age given on this page.

You can make first contact with the group through attendance at one of our regular monthly meetings or coffee and chat mornings.  However, if you have immediate concerns about prostate health or problems and would like to discuss them now, don't wait for a meeting - contact us now by phone or email - contact details are on
this page.

Promoting the need for testing at an appropriate age

The group is very active within the ACT and surrounding region in promoting awareness about prostate cancer, its diagnosis and treatment. Most men are unaware of the incidence of prostate cancer: each year about 20,000 men are newly diagnosed as having prostate cancer and about 3,300 die of prostate cancer.

Most people are unaware of the fact that prostate cancer usually develops without any noticeable symptoms. The consensus amongst our group is that it is important that all men be aware of this and that they talk to their GP about monitoring the level of PSA (Prostate Specific Antigen) through regular testing, commencing at an appropriate age. That approach increases the likelihood of early detection, with the important consequence of maximising the chances of a completely effective treatment. What comprises an appropriate age is specified in guidelines that have been
approved by the National Health and Medical Research Council. Those guidelines have been endorsed by the Prostate cancer Foundation of Australia (PCFA), the Cancer Council Australia and the Urological Society of Australia and New Zealand. The guidelines can be read or downloaded from this page of the PCFA web site: http://tinyurl.com/yc4ryzwy In particular men might note the contents of the document referred to as An overview of the recommendations approved by the National Health and Medical Research Council. On page 3 of the document the "take home message" concerning initial testing is this:

Men should be offered the opportunity to consider and discuss the benefits and harms of PSA testing before making the decision whether or not to be tested.  
  • The harms of PSA testing may outweigh the benefits, particularly for men aged 70 and older.
  • Men at average risk of prostate cancer who decide to undergo regular testing should be offered PSA testing every 2 years from age 50 to 69.
  • Men with a family history of prostate cancer who decide to be tested should be offered PSA testing every 2 years from age 40/45 to 69, with the starting age depending on the strength of their family history.
  • Digital rectal examination is not recommended for asymptomatic men as a routine addition to PSA testing in the primary care setting, but remains an important part of specialist assessment.

The consensus amongst our group is that regular and early testing is particularly important amongst men for whom risk of prostate cancer is higher than for other men as a consequence of family history of cancer and their ethnicity.  

Providing information

While your GP and specialist would be your primary source of information about prostate cancer there are many supplementary sources of information about the diagnosis and treatment of prostate cancer and after-treatment care. This includes
publications in print and audiovisual format and there are many organisations, service agencies and friendly associations that provide information, services and support.

The group maintains a library of selected publications that people can borrow (see
Our library).

Information about the group’s activities are published in our free newsletter The Walnut (see Our newsletter).

There is good news!

The good news is that there is strong evidence that in many cases treatment of prostate cancer can result in long term remission or cure. This is especially so if prostate cancer has been detected at an early stage. Early detection is the key to enabling a completely effective treatment with least possible side effects. However, even if not detected early in its development, there are treatments which can control many of the associated symptoms and problems, enabling an enjoyable and useful life for many years.

In 2017 prostate cancer was estimated to be the most commonly diagnosed form of cancer in males, and the second highest cause of death from cancer among males. However, there are important ‘good news’ messages:
  • There is strong evidence that in many cases treatment of prostate cancer can result in long term remission, particularly when it has been detected at an early stage.
  • Even if it is not detected early in its development, there are treatments which can still control many of the associated symptoms and problems, enabling an enjoyable and useful life for many years.
Fortunately, prostate cancer is often very slow growing and therefore many men will survive their cancer for many years. For example, the latest available official Australian Government statistics show that for the period 2009-2013, the five-year ‘relative survival rate’ for prostate cancer was 95%. This is a better survival rate than for any any other cancer amongst males.

Another cause for optimism is that survival rates for prostate cancer are improving. The five-year relative survival rate for prostate cancer improved from 85% for the period 1998-2004. With more frequent use of and improving diagnostic procedures, better treatment protocols and earlier detection there should be even further improvements in the future.

The source of the above statistics is the Australian Institute of Health and Welfare’s publication Cancer in Australia in Brief 2017. This report and others can be downloaded from here: https://tinyurl.com/y5sza5r4

On a more personal note, a considerable number of our group have undertaken treatment for prostate cancer and their cancer is in remission. The medical literature indicates that there are good chances of treatment leading to a state of remission when the cancer is detected early enough. This is particularly so when the cancer is confined within the prostate capsule. There is clear evidence that if the cancer is not totally contained within the prostate capsule, the probability that treatment can lead to long-term remission is reduced. Hence the importance of early detection.

While a cure may not be achievable for some men, there are treatments that enable most men to have a satisfying life for many years. These treatments and approaches to symptom and problem management are explained in detail in the books and documents
listed here.

Links with other organisations

The group is affiliated with the Prostate Cancer Foundation of Australia being a member of its Support Group network.


Contact us

If you would like to get more information about the group please contact us - see details on this page. Alternatively, simply come along to a monthly meeting - all people are welcome to attend.


On this web site is provided information about developments in the diagnosis and treatment of prostate cancer, books, documents, audiovisual products, presentations, research articles, sources of information, and other materials. However, the Group's Executive and web site manager do not have the medical expertise required to make an informed evaluation of conclusions and recommendations presented in such materials, and such conclusions and recommendations have not been verified through appropriately qualified medical professionals.

The information presented on this site must not be interpreted as being endorsed or recommended by the Group's Executive or web site manager. Any recommendations made in materials that are on the site or referred to may not be applicable in your particular case. Before implementing any recommendations made in the materials that are reported or referred to, it is essential that you obtain advice from appropriately qualified medical professionals.

The view of the Group
ΚΌs Executive is that no two prostate cancer cases are alike and that no single treatment option is better than any other in all cases. While the information on this site should be of interest, there is no substitute for getting informed medical advice from your own GP, specialists and other medical professionals.